CRVL

CorVel Corporation

Financial Services · $3.8B market cap

Verdict

Share price

$75.47

close of Oct 3, 2026

Fair value

$44.79

Sticker Price

Payback Price

$17.91

buy price

Overpriced

CRVL is Overpriced: at $75.47 it trades 69% above its fair value of $44.79. Its buy price (Payback Price) is $17.91, 76% below today's price. Business quality is mixed: 2 of 5 key numbers clear the 10% bar.

How we valued it

Free Cash Flow. Sales grew 10% a year over the last 3 years, below the 15% we look for in a fast grower, so we value it on its free cash flow instead of an earnings forecast.

Business quality

2 of 5 clear the 10% bar. What are the Big Five?

Earnings per share growth8.7% a year✗
Equity per share growth11.3% a year✓
Sales growth6.2% a year✗
Free cash flow growth8.4% a year✗
Return on invested capital26.9%✓

Follow CRVL

Get notified when it reaches its buy price of $17.91. Free.

Create a free account

Insider activity

Since Jun 12, 2026: no open-market purchases, 8 sales worth $5.4M and 16 other filings (stock awards, tax withholding and similar). Why purchases matter

Sales

Other filings

About CorVel Corporation

CorVel Corporation delivers comprehensive solutions designed to assist employers, third-party administrators, insurance providers, and government entities in effectively managing healthcare claims. The company focuses on controlling medical expenditures and ensuring high-quality care across various sectors, including workers' compensation, auto liability, and general health. Leveraging advanced technologies such as…

Insurance - Brokers

Fair value and Payback Price are estimates from the company's reported financials, not investment advice. Prices as of the close of Oct 3, 2026. How the Payback Price works